MIC
OM icon

Mubadala Investment Company’s Outset Medical OM Stock Holding History

Mubadala Investment Company’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-96,040
Closed -$975K – 58
2024
Q3 		$975K Hold
96,040
– – 0.01% 12
2024
Q2 		$5.55M Hold
96,040
– – 0.02% 16
2024
Q1 		$3.2M Hold
96,040
– – 0.01% 17
2023
Q4 		$7.79M Buy
+96,040
New +$7.81M 0.03% 17

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mubadala Investment Company's OM Position: Q4 2024 in Review

Mubadala Investment Company sold out of Outset Medical (OM) in Q4 2024, closing a stake of 96,040 shares — an estimated $975K sold.

Mubadala Investment Company first reported a position in OM in Q4 2023 and held it in 4 quarters. The position peaked at $7.79M in Q4 2023. 73 funds tracked by Wall St. Rank hold OM as of Q4 2024.

  • Mubadala Investment Company reported no remaining Outset Medical position as of Q4 2024 after selling out during the quarter.
  • Mubadala Investment Company sold 96,040 Outset Medical shares in Q4 2024, an estimated $975K.
  • Mubadala Investment Company first reported a position in Outset Medical in Q4 2023 and held it in 4 quarters.
  • Mubadala Investment Company's Outset Medical position peaked at $7.79M in Q4 2023.
  • 73 funds tracked by Wall St. Rank held Outset Medical as of Q4 2024.

Based on Mubadala Investment Company's 13F filing for Q4 2024, filed 14 Feb 2025.